HIV and antiretroviral therapy-related fat alterations

JR Koethe, C Lagathu, JE Lake, P Domingo… - Nature reviews Disease …, 2020 - nature.com
Early in the HIV epidemic, lipodystrophy, characterized by subcutaneous fat loss
(lipoatrophy), with or without central fat accumulation (lipohypertrophy), was recognized as a …

Lipodystrophy: pathophysiology and advances in treatment

CG Fiorenza, SH Chou, CS Mantzoros - Nature Reviews Endocrinology, 2011 - nature.com
Lipodystrophy is a medical condition characterized by complete or partial loss of adipose
tissue. Not infrequently, lipodystrophy occurs in combination with pathological accumulation …

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

F Benhamed, PD Denechaud… - The Journal of …, 2012 - Am Soc Clin Investig
Nonalcoholic fatty liver disease (NAFLD) is associated with all features of the metabolic
syndrome. Although deposition of excess triglycerides within liver cells, a hallmark of …

Aggregating in vitro-grown adipocytes to produce macroscale cell-cultured fat tissue with tunable lipid compositions for food applications

JSK Yuen Jr, MK Saad, N Xiang, BM Barrick… - Elife, 2023 - elifesciences.org
We present a method of producing bulk cell-cultured fat tissue for food applications. Mass
transport limitations (nutrients, oxygen, waste diffusion) of macroscale 3D tissue culture are …

Mitochondrial (dys) function in adipocyte (de) differentiation and systemic metabolic alterations

A De Pauw, S Tejerina, M Raes, J Keijer… - The American journal of …, 2009 - Elsevier
In mammals, adipose tissue, composed of BAT and WAT, collaborates in energy partitioning
and performs metabolic regulatory functions. It is the most flexible tissue in the body …

Adipogenesis: cellular and molecular aspects

B Fève - Best Practice & Research Clinical Endocrinology & …, 2005 - Elsevier
Obesity and lipoatrophy are major risks for insulin resistance, non-insulin-dependent
diabetes and cardiovascular disease. In the past three decades, significant advances have …

HIV-associated lipodystrophy: from fat injury to premature aging

M Caron-Debarle, C Lagathu, F Boccara… - Trends in molecular …, 2010 - cell.com
Combination antiretroviral therapy (cART) against HIV infection dramatically reduces AIDS-
related morbidity. However, many patients under cART display HIV-associated …

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled …

ENCORE1 Study Group - The Lancet, 2014 - Elsevier
Background The optimum dose of key antiretroviral drugs is often overlooked during product
development. The ENCORE1 study compared the efficacy and safety of reduced dose …

Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition

N Apostolova, A Blas-García, JV Esplugues - Trends in pharmacological …, 2011 - cell.com
The combined pharmacological approach to the treatment of HIV infection, known as highly
active antiretroviral therapy (HAART), has dramatically reduced AIDS-related morbidity and …

[PDF][PDF] Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

A Blas‐García, N Apostolova, D Ballesteros… - …, 2010 - Wiley Online Library
Efavirenz (EFV) is a non‐nucleoside reverse transcriptase inhibitor (NNRTI) widely used in
human immunodeficiency virus (HIV) infection therapy. It has been associated with …